Sentences with phrase «metastatic breast cancer research»

METAvivor is the only organization in the US to specifically fund Stage IV Metastatic Breast Cancer research.

Today I wanted to talk about ToteSavvy and their cause to raise money for Metastatic Breast Cancer research.

Not exact matches

I'm battling metastatic breast cancer and have done lots of research on the anti-cancer and anti-inflammatory benefits of turmeric.

«This study may have implications not only for breast cancer, but for many metastatic cancers,» said Ravi Thadhani, MD, MPH, vice dean, Research and Graduate Research Education, at Cedars - Sinai.

Ziskin, a Hollywood film producer who died of metastatic breast cancer, was a co-founder of Stand Up To Cancer, an initiative founded in 2008 by nine women in the entertainment industry to accelerate groundbreaking research and bring new treatments to patients as quickly as poscancer, was a co-founder of Stand Up To Cancer, an initiative founded in 2008 by nine women in the entertainment industry to accelerate groundbreaking research and bring new treatments to patients as quickly as posCancer, an initiative founded in 2008 by nine women in the entertainment industry to accelerate groundbreaking research and bring new treatments to patients as quickly as possible.

Most of the research into breast cancer has focused on primary breast cancer, and there is little understanding of the biology underpinning breast cancer that has spread to other parts of the body, known as metastatic cancer.

Human breast tumors transplanted into mice are excellent models of metastatic cancer and are providing insights into how to attack breast cancers that no longer respond to the drugs used to treat them, according to research from Washington University School of Medicine in St. Louis.

Tags: big data, Breast Cancer Research Program, cancer genomics, cancer patients, genomics, genomics database, metastatic breast cancer, Public Health Sciences, socialBreast Cancer Research Program, cancer genomics, cancer patients, genomics, genomics database, metastatic breast cancer, Public Health Sciences, socialCancer Research Program, cancer genomics, cancer patients, genomics, genomics database, metastatic breast cancer, Public Health Sciences, socialcancer genomics, cancer patients, genomics, genomics database, metastatic breast cancer, Public Health Sciences, socialcancer patients, genomics, genomics database, metastatic breast cancer, Public Health Sciences, socialbreast cancer, Public Health Sciences, socialcancer, Public Health Sciences, social media

The intent of our research into metastatic breast cancer is to improve the treatments available to patients with this disease, to increase their chance of long - term survival and, ultimately, to reduce the burden of metastatic disease by preventing its occurrence.

Our goal is to reach out to patients with metastatic breast cancer throughout the USA and Canada in order to study their cancer using cutting - edge genomic and molecular research studies performed at the Broad Institute by allowing patients to participate in these studies regardless of where they live.

We have established a technique to generate syngeneic murine metastatic breast cancer model that mimic human breast cancer progression (Rashid OM et al, Breast Cancer Research and Treatment breast cancer model that mimic human breast cancer progression (Rashid OM et al, Breast Cancer Research and Treatment cancer model that mimic human breast cancer progression (Rashid OM et al, Breast Cancer Research and Treatment breast cancer progression (Rashid OM et al, Breast Cancer Research and Treatment cancer progression (Rashid OM et al, Breast Cancer Research and Treatment Breast Cancer Research and Treatment Cancer Research and Treatment 2014).

Tags: advocacy, Breast Cancer, breast cancer advocacy, breast cancer awareness month, Clinical Research Division, Fred Hutch, Karen Syrjala, metastatic breast cancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship PBreast Cancer, breast cancer advocacy, breast cancer awareness month, Clinical Research Division, Fred Hutch, Karen Syrjala, metastatic breast cancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship PCancer, breast cancer advocacy, breast cancer awareness month, Clinical Research Division, Fred Hutch, Karen Syrjala, metastatic breast cancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship Pbreast cancer advocacy, breast cancer awareness month, Clinical Research Division, Fred Hutch, Karen Syrjala, metastatic breast cancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship Pcancer advocacy, breast cancer awareness month, Clinical Research Division, Fred Hutch, Karen Syrjala, metastatic breast cancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship Pbreast cancer awareness month, Clinical Research Division, Fred Hutch, Karen Syrjala, metastatic breast cancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship Pcancer awareness month, Clinical Research Division, Fred Hutch, Karen Syrjala, metastatic breast cancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship Pbreast cancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship Pcancer, SCCA, Seattle Cancer Care Alliance, survivorship, Survivorship PCancer Care Alliance, survivorship, Survivorship Program

CRI postdoctoral fellow Dr. Haihui Lu at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, is studying some of the unique characteristics that differentiate metastatic cancer cells from primary tumor cells, and specifically aims to understand how these unique characteristics enable breast cancer cells to escape elimination by the immune system.

Low levels of a tiny RNA fragment in cells are associated with metastatic breast cancer in humans and increases the aggressive spread of breast cancer in mice, according to researchers at Whitehead Institute for Biomedical Research.

The main focus of my research program is on design and preclinical evaluation of novel therapeutic strategies for treatment of metastatic cancers, including breast cancer and melanoma.

Tags: breast cancer advocacy, Cierra Sisters, Clinical Research, Clinical Research Division, Hannah Linden, health disparities, Julie Gralow, Kevin Cheung, lobular breast cancer, metastatic breast cancer, Public Health Sciences Division (PHS), Ruth Etzioni, Vijayakrishna Gadi

Tags: Andrew Hsieh, Biostatistics and Biomathematics Program, Cancer etiology - prevention - outcomes, Cancer Prevention Program, Cancer Surveillance System, Christopher J Kemp, Good News, Kevin Cheung, Marian Neuhouser, metastatic breast cancer, Peggy Porter, Peter Nelson, Public Health Sciences, Roland Walter, Ruth Etzioni, Sage Bionetworks, SCCA, Seattle Cancer Care Alliance (SCCA), Seattle Translational Tumor Research, STTR cancer, Tumor specific translational research, UW MeCancer etiology - prevention - outcomes, Cancer Prevention Program, Cancer Surveillance System, Christopher J Kemp, Good News, Kevin Cheung, Marian Neuhouser, metastatic breast cancer, Peggy Porter, Peter Nelson, Public Health Sciences, Roland Walter, Ruth Etzioni, Sage Bionetworks, SCCA, Seattle Cancer Care Alliance (SCCA), Seattle Translational Tumor Research, STTR cancer, Tumor specific translational research, UW MeCancer Prevention Program, Cancer Surveillance System, Christopher J Kemp, Good News, Kevin Cheung, Marian Neuhouser, metastatic breast cancer, Peggy Porter, Peter Nelson, Public Health Sciences, Roland Walter, Ruth Etzioni, Sage Bionetworks, SCCA, Seattle Cancer Care Alliance (SCCA), Seattle Translational Tumor Research, STTR cancer, Tumor specific translational research, UW MeCancer Surveillance System, Christopher J Kemp, Good News, Kevin Cheung, Marian Neuhouser, metastatic breast cancer, Peggy Porter, Peter Nelson, Public Health Sciences, Roland Walter, Ruth Etzioni, Sage Bionetworks, SCCA, Seattle Cancer Care Alliance (SCCA), Seattle Translational Tumor Research, STTR cancer, Tumor specific translational research, UW Mecancer, Peggy Porter, Peter Nelson, Public Health Sciences, Roland Walter, Ruth Etzioni, Sage Bionetworks, SCCA, Seattle Cancer Care Alliance (SCCA), Seattle Translational Tumor Research, STTR cancer, Tumor specific translational research, UW MeCancer Care Alliance (SCCA), Seattle Translational Tumor Research, STTR cancer, Tumor specific translational research, UW Research, STTR cancer, Tumor specific translational research, UW Mecancer, Tumor specific translational research, UW research, UW Medicine

This year, Komen has set a goal to reduce breast cancer deaths by 50 percent in 10 years by, among other things, enhancing their focus on research to cure these forms of breast cancer and metastatic disease.